The Apex Times
Above the Noise
Business Wire
BusinessAEP signs agreement framework for 960-MW Indiana nuclear project tied to Amazon power demand and X-energy technologyThe Apex TimesBusinessJPMorgan expands JPM Coin usage to Ethereum, indicating push for broader blockchain liquidityThe Apex TimesBusinessPalantir pushes further into commercial business as it tries to outgrow its government rootsThe Apex TimesBusinessUber Says Its Ride-Hailing Cash Flow Helps, but Robotaxi Spending Could Still Decide the ValuationThe Apex TimesBusinessKFC’s switch from Pepsi to Coke reignites beverage rivalry at fast-food checkoutsThe Apex TimesBusinessSpeculation Swirls Around a Potential SpaceX-Tesla Deal Before 2026 Ends, Stirring Talk of Stock ImplicationsThe Apex TimesBusinessApple’s first foldable phone, called the “iPhone Duo,” triggers a rapid preorder sellout and boosts investor sentimentThe Apex TimesBusinessMorgan Stanley lifts its META price target, citing AI upside but presses on Muse’s daily user growthThe Apex TimesBusinessIntel Shares Rise After JPMorgan Drops Sell Rating, Indicating Shift in Investor SentimentThe Apex TimesBusinessMeta off-balance-sheet financing figure balloons, analyst says, as company tries to protect free cash flowThe Apex TimesBusinessLockheed Martin prepares for 2027 rare-earth magnet sourcing rules, as scrutiny of China-linked supply growsThe Apex TimesBusinessGE Aerospace deal puts GE back in the aviation spotlight, after agreeing to buy castings supplier Consolidated Precision Products in an $11.75 billion transactionThe Apex TimesBusinessAEP signs agreement framework for 960-MW Indiana nuclear project tied to Amazon power demand and X-energy technologyThe Apex TimesBusinessJPMorgan expands JPM Coin usage to Ethereum, indicating push for broader blockchain liquidityThe Apex TimesBusinessPalantir pushes further into commercial business as it tries to outgrow its government rootsThe Apex TimesBusinessUber Says Its Ride-Hailing Cash Flow Helps, but Robotaxi Spending Could Still Decide the ValuationThe Apex TimesBusinessKFC’s switch from Pepsi to Coke reignites beverage rivalry at fast-food checkoutsThe Apex TimesBusinessSpeculation Swirls Around a Potential SpaceX-Tesla Deal Before 2026 Ends, Stirring Talk of Stock ImplicationsThe Apex TimesBusinessApple’s first foldable phone, called the “iPhone Duo,” triggers a rapid preorder sellout and boosts investor sentimentThe Apex TimesBusinessMorgan Stanley lifts its META price target, citing AI upside but presses on Muse’s daily user growthThe Apex TimesBusinessIntel Shares Rise After JPMorgan Drops Sell Rating, Indicating Shift in Investor SentimentThe Apex TimesBusinessMeta off-balance-sheet financing figure balloons, analyst says, as company tries to protect free cash flowThe Apex TimesBusinessLockheed Martin prepares for 2027 rare-earth magnet sourcing rules, as scrutiny of China-linked supply growsThe Apex TimesBusinessGE Aerospace deal puts GE back in the aviation spotlight, after agreeing to buy castings supplier Consolidated Precision Products in an $11.75 billion transactionThe Apex TimesBusinessAEP signs agreement framework for 960-MW Indiana nuclear project tied to Amazon power demand and X-energy technologyThe Apex TimesBusinessJPMorgan expands JPM Coin usage to Ethereum, indicating push for broader blockchain liquidityThe Apex TimesBusinessPalantir pushes further into commercial business as it tries to outgrow its government rootsThe Apex TimesBusinessUber Says Its Ride-Hailing Cash Flow Helps, but Robotaxi Spending Could Still Decide the ValuationThe Apex TimesBusinessKFC’s switch from Pepsi to Coke reignites beverage rivalry at fast-food checkoutsThe Apex TimesBusinessSpeculation Swirls Around a Potential SpaceX-Tesla Deal Before 2026 Ends, Stirring Talk of Stock ImplicationsThe Apex TimesBusinessApple’s first foldable phone, called the “iPhone Duo,” triggers a rapid preorder sellout and boosts investor sentimentThe Apex TimesBusinessMorgan Stanley lifts its META price target, citing AI upside but presses on Muse’s daily user growthThe Apex TimesBusinessIntel Shares Rise After JPMorgan Drops Sell Rating, Indicating Shift in Investor SentimentThe Apex TimesBusinessMeta off-balance-sheet financing figure balloons, analyst says, as company tries to protect free cash flowThe Apex TimesBusinessLockheed Martin prepares for 2027 rare-earth magnet sourcing rules, as scrutiny of China-linked supply growsThe Apex TimesBusinessGE Aerospace deal puts GE back in the aviation spotlight, after agreeing to buy castings supplier Consolidated Precision Products in an $11.75 billion transactionThe Apex TimesBusinessAEP signs agreement framework for 960-MW Indiana nuclear project tied to Amazon power demand and X-energy technologyThe Apex TimesBusinessJPMorgan expands JPM Coin usage to Ethereum, indicating push for broader blockchain liquidityThe Apex TimesBusinessPalantir pushes further into commercial business as it tries to outgrow its government rootsThe Apex TimesBusinessUber Says Its Ride-Hailing Cash Flow Helps, but Robotaxi Spending Could Still Decide the ValuationThe Apex TimesBusinessKFC’s switch from Pepsi to Coke reignites beverage rivalry at fast-food checkoutsThe Apex TimesBusinessSpeculation Swirls Around a Potential SpaceX-Tesla Deal Before 2026 Ends, Stirring Talk of Stock ImplicationsThe Apex TimesBusinessApple’s first foldable phone, called the “iPhone Duo,” triggers a rapid preorder sellout and boosts investor sentimentThe Apex TimesBusinessMorgan Stanley lifts its META price target, citing AI upside but presses on Muse’s daily user growthThe Apex TimesBusinessIntel Shares Rise After JPMorgan Drops Sell Rating, Indicating Shift in Investor SentimentThe Apex TimesBusinessMeta off-balance-sheet financing figure balloons, analyst says, as company tries to protect free cash flowThe Apex TimesBusinessLockheed Martin prepares for 2027 rare-earth magnet sourcing rules, as scrutiny of China-linked supply growsThe Apex TimesBusinessGE Aerospace deal puts GE back in the aviation spotlight, after agreeing to buy castings supplier Consolidated Precision Products in an $11.75 billion transactionThe Apex Times
Back to front
Eli Lilly’s Foundayo Seen as Positioned to Gain Share, BofA Says
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 19, 10:57 AM EDT

Eli Lilly’s Foundayo Seen as Positioned to Gain Share, BofA Says

A Bank of America note highlighted Lilly’s oral GLP-1 treatment, Foundayo, as a likely driver of continued market share gains over the coming year, according to a report carried by Yahoo Finance.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Eli Lilly’s oral GLP-1 therapy, Foundayo, is expected to keep gaining market share over the next 12 months, a Bank of America assessment cited by Yahoo Finance said in a market update published October 19, 2026.

The Yahoo Finance report attributes the view to BofA analysts, framing Foundayo as a product that should continue to expand its presence in an increasingly crowded GLP-1 market. The post does not provide specific figures in the excerpt available here, nor does it describe the underlying demand, pricing, or channel assumptions behind the firm’s outlook.

Foundayo matters to Lilly because it represents the company’s push beyond injectable-only GLP-1 treatments. In this drug class, oral formulations are a strategic differentiator, aimed at improving convenience and potentially widening the addressable patient population, particularly for patients who prefer tablets over injections.

The broader context is that GLP-1 therapies have moved quickly from niche usage to mainstream prescribing for weight management and related metabolic conditions. As more products compete in the category, analysts and investors typically focus on share dynamics, retention, and how quickly new entrants or adjacent formulations can win prescriptions.

For Lilly, market share growth would also be relevant to balancing growth across its portfolio as competition increases. The oral format highlighted in the report is often evaluated by the market on adoption trajectory, prescriber comfort, and patient switching from existing GLP-1 brands, though the Yahoo Finance update available here does not spell out which of those factors BofA emphasized.

What the report does not disclose in the excerpt is equally important. It does not include BofA’s target metrics, valuation implications, updated estimates, or any stated probability of outcomes. It also does not mention whether BofA expects share gains to come from new patients, patients switching brands, payer coverage changes, or distribution expansion.

Until more detail is published, investors and other readers will have to treat the market share claim as directional rather than quantifiable. The BofA conclusion indicates confidence in Foundayo’s ability to compete over the next year, but the absence of disclosed assumptions limits how precisely outsiders can interpret the drivers behind the forecast.

Why It Matters

  • Market share gains in GLP-1s are a central factor for how quickly firms can grow revenue as the category scales.
  • An oral GLP-1 format can influence adoption by changing patient convenience and prescribing behavior compared with injections.
  • BofA’s stance may affect near-term sentiment around Lilly’s competitiveness versus other GLP-1 offerings.
  • Because the report does not share figures or detailed assumptions, the practical impact for forecasting depends on further disclosures.

Sources

Key Facts

  • Yahoo Finance reported that Bank of America expects Eli Lilly’s Foundayo to keep gaining market share over the next 12 months.
  • The report characterizes Foundayo as a continued driver of share growth rather than a one-time adoption spike.
  • Foundayo is Lilly’s oral GLP-1 treatment, distinguishing it from injection-only therapies in the same class.
  • The Yahoo Finance excerpt does not provide specific numeric targets, estimate changes, or detailed rationale.
  • The update offers a directional view on market share but does not describe the underlying assumptions (such as pricing, coverage, or switching).

Healthcare Related